Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Myriad Genetics (MYGN) over the last 16 years, with Q3 2025 value amounting to $353.6 million.

  • Myriad Genetics' Total Non-Current Liabilities rose 1214.72% to $353.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $353.6 million, marking a year-over-year increase of 1214.72%. This contributed to the annual value of $324.3 million for FY2024, which is 71.43% up from last year.
  • Per Myriad Genetics' latest filing, its Total Non-Current Liabilities stood at $353.6 million for Q3 2025, which was up 1214.72% from $287.3 million recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Total Non-Current Liabilities registered a high of $440.6 million during Q2 2023, and its lowest value of $235.1 million during Q2 2022.
  • Over the past 5 years, Myriad Genetics' median Total Non-Current Liabilities value was $320.8 million (recorded in 2021), while the average stood at $330.2 million.
  • As far as peak fluctuations go, Myriad Genetics' Total Non-Current Liabilities tumbled by 4492.86% in 2022, and later soared by 8740.96% in 2023.
  • Over the past 5 years, Myriad Genetics' Total Non-Current Liabilities (Quarter) stood at $320.8 million in 2021, then fell by 16.15% to $269.0 million in 2022, then increased by 19.7% to $322.0 million in 2023, then rose by 0.71% to $324.3 million in 2024, then rose by 9.03% to $353.6 million in 2025.
  • Its Total Non-Current Liabilities stands at $353.6 million for Q3 2025, versus $287.3 million for Q2 2025 and $299.2 million for Q1 2025.